Glasgow, Scotland, UK
10-13 June, 2023

Join us for the

European Society of Human Genetics Conference 2023!

Asuragen, a Bio-Techne brand’s unique and proprietary AmplideX® and QuantideX® chemistries power simple and streamlined solutions for analysis of complex genomic targets.

Visit us at stand #268

Asuragen Corporate Satellite

Alsh 1, level 0
Sunday, 11 June 12:00 – 13:00 hrs
Virtual Platform: Live Stream & On Demand

C9orf72 in FTD and ALS: How genetic testing holds the key to improving patient outcomes

This session explores how C9orf72 is a biomarker for Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). We also discuss how the AmplideX C9orf72 Kit* enables accurate detection of expansions in this gene.

Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degenerations: Similarities in the Genetic Background Mainly Due to C9orf72

Pr. Vincenzo Silani

Professor of Neurology, Department of Neuroscience, IRCCS Istituto Auxologico Italiano

University of Milan Medical School

Application of the AmplideX® C9orf72 Assay to Standardise Genetic Testing of FTD and ALS

Pr. Emiliano Giardina

Director of the Laboratory of Genomic Medicine, Fondazione Santa Lucia IRCCS

University of Rome “Tor Vergata”

Stream Here

Find out more about ESHG

Learn More
Back To